SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001662579-24-000044
Filing Date
2024-06-11
Accepted
2024-06-11 16:45:09
Documents
2
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1718138702.html 3  
1 FORM 3 wk-form3_1718138702.xml 3 1637
2 EX-24 cooper.txt EX-24 4291
  Complete submission text file 0001662579-24-000044.txt   7443
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Cooper Ronald Harold Wilfred (Reporting) CIK: 0001676880 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39567 | Film No.: 241036395